A Role for FDG-PET in the Surgical Management of Stage IV Melanoma
- 1 August 2004
- journal article
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 11 (8) , 721-722
- https://doi.org/10.1245/aso.2004.06.923
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Prospective Analysis of Positron Emission Tomography and Conventional Imaging for Detection of Stage IV Metastatic Melanoma in Patients Undergoing MetastasectomyAnnals of Surgical Oncology, 2004
- Positron emission tomography is superior to computed tomography for metastatic detection in melanoma patientsAnnals of Surgical Oncology, 2002
- FDG–PET sensitivity for melanoma lymph node metastases is dependent on tumor volumeJournal of Surgical Oncology, 2001
- Comparison of Positron Emission Tomography Scanning and Sentinel Node Biopsy in the Detection of Micrometastases of Primary Cutaneous Malignant MelanomaJournal of Clinical Oncology, 2001
- Positron emission tomography scanning in malignant melanomaCancer, 2000
- Prospective Study of Fluorodeoxyglucose–Positron Emission Tomography Imaging of Lymph Node Basins in Melanoma Patients Undergoing Sentinel Node BiopsyJournal of Clinical Oncology, 1999
- Effectiveness of Positron Emission Tomography for the Detection of Melanoma MetastasesAnnals of Surgery, 1998
- Positron emission tomography in the detection and management of metastatic melanomaMelanoma Research, 1996
- Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose.Radiology, 1995
- Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucoseBritish Journal of Dermatology, 1995